{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:51:02Z","timestamp":1778946662183,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00535-012-0679-8","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T06:35:04Z","timestamp":1349332504000},"page":"847-855","source":"Crossref","is-referenced-by-count":20,"title":["Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis"],"prefix":"10.1007","volume":"48","author":[{"given":"Yuko","family":"Nagaoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Aikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Naeshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohji","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Miyaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Hyogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiiku","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"key":"679_CR1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","volume":"43","author":"A Sangiovanni","year":"2006","unstructured":"Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology. 2006;43:1303\u201310.","journal-title":"Hepatology"},{"key":"679_CR2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2009.31","volume":"104","author":"S Bruno","year":"2009","unstructured":"Bruno S, Zuin M, Crosignani A, Rossi S, Zadra F, Roffi L, et al. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Am J Gastroenterol. 2009;104:1147\u201358.","journal-title":"Am J Gastroenterol"},{"key":"679_CR3","doi-asserted-by":"crossref","unstructured":"Benvegn\u00fa L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut. 2004;53:744\u20139.","DOI":"10.1136\/gut.2003.020263"},{"key":"679_CR4","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.510270529","volume":"27","author":"A Kasahara","year":"1998","unstructured":"Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology. 1998;27:1394\u2013402.","journal-title":"Hepatology"},{"key":"679_CR5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hep.510290439","volume":"29","author":"K Ikeda","year":"1999","unstructured":"Ikeda K, Saitoh S, Arase Y, Chayama K, Suzuki Y, Kobayashi M, et al. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1643 patients using statistical bias correction with proportional hazard analysis. Hepatology. 1999;29:1124\u201330.","journal-title":"Hepatology"},{"key":"679_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/gut.2003.030353","volume":"53","author":"H Yoshida","year":"2004","unstructured":"Yoshida H, Tateishi R, Arakawa Y, Sata M, Fujiyama S, Nishiguchi S, et al. Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C. Gut. 2004;53:425\u201330.","journal-title":"Gut"},{"key":"679_CR7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(95)91739-X","volume":"346","author":"S Nishiguchi","year":"1995","unstructured":"Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995;346:1051\u20135.","journal-title":"Lancet"},{"key":"679_CR8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(98)07236-5","volume":"351","author":"International Interferon-alpha Hepatocellular Carcinoma Study Group","year":"1998","unstructured":"International Interferon-alpha Hepatocellular Carcinoma Study Group. Effect of interferon alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet. 1998;351:1535\u20139.","journal-title":"Lancet"},{"key":"679_CR9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/hep.510290424","volume":"29","author":"KQ Hu","year":"1999","unstructured":"Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology. 1999;29:1311\u20136.","journal-title":"Hepatology"},{"key":"679_CR10","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.3748\/wjg.v13.i39.5188","volume":"13","author":"S Jeong","year":"2007","unstructured":"Jeong S, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, et al. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma. World J Gastroenterol. 2007;13:5188\u201395.","journal-title":"World J Gastroenterol"},{"key":"679_CR11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1440-1746.2001.02450.x","volume":"16","author":"K Ikeda","year":"2001","unstructured":"Ikeda K, Saitoh S, Koboyashi M, Suzuki Y, Suzuki A, Tsubota A, et al. Long-term interferon therapy for 1\u00a0year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study. J Gastroenterol Hepatol. 2001;16:406\u201315.","journal-title":"J Gastroenterol Hepatol"},{"key":"679_CR12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199904013401302","volume":"340","author":"SK Sarin","year":"1999","unstructured":"Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med. 1999;340:988\u201393.","journal-title":"N Engl J Med"},{"key":"679_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2003.07.016","volume":"313","author":"H Moriwaki","year":"2004","unstructured":"Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M. Branched-chain amino acids as a protein and energy source in liver cirrhosis. Biochem Biophys Res Commun. 2004;313:405\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"679_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00063-007-1056-x","volume":"102","author":"F Gundling","year":"2007","unstructured":"Gundling F, Teich N, Strebel HM, Schepp W, Pehl C. Nutrition in liver cirrhosis. Med Klin. 2007;102:435\u201344.","journal-title":"Med Klin"},{"key":"679_CR15","first-page":"332","volume":"22","author":"G D\u2019Amico","year":"1995","unstructured":"D\u2019Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332\u201354.","journal-title":"Hepatology"},{"key":"679_CR16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.510250608","volume":"25","author":"CS Lay","year":"1997","unstructured":"Lay CS, Tsai YT, Teg CY, Shyu WS, Guo WS, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhosis patients with high-risk esophageal varices. Hepatology. 1997;25:1346\u201350.","journal-title":"Hepatology"},{"key":"679_CR17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/gast.2001.22580","volume":"120","author":"G Garcia-Tsao","year":"2001","unstructured":"Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001;120:726\u201348.","journal-title":"Gastroenterology"},{"key":"679_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-117-1-59","volume":"117","author":"L Pagliaro","year":"1992","unstructured":"Pagliaro L, D\u2019Amico G, Sorensen TI, Lebrec D, Burroughs AK, Morabito A, et al. Prevention of first bleeding in cirrhosis: a meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med. 1992;117:59\u201370.","journal-title":"Ann Intern Med"},{"key":"679_CR19","unstructured":"The Japan Society for Portal Hypertension and Esophageal Varices. The general rules for study of portal hypertension. 2nd ed. Tokyo: Kanehara; 2004. p. 37\u20138 (in Japanese)."},{"key":"679_CR20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0168-8278(01)00005-8","volume":"34","author":"C Camm\u00e0","year":"2001","unstructured":"Camm\u00e0 C, Giunta M, Andreone P, Craxi A. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol. 2001;34:593\u2013602.","journal-title":"J Hepatol"},{"key":"679_CR21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM200012073432302","volume":"343","author":"EJ Heathcote","year":"2000","unstructured":"Heathcote EJ, Shiffman ML, Cooksley WG, Samuel S, Lee SS, Balart L, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med. 2000;343:1673\u201380.","journal-title":"N Engl J Med"},{"key":"679_CR22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/hep.20073","volume":"39","author":"C Camm\u00e0","year":"2004","unstructured":"Camm\u00e0 C, Di Bona D, Schepis F, Heathcote J, Stefan Zeuzem S, Pockros PJ, et al. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. Hepatology. 2004;39:333\u201342.","journal-title":"Hepatology"},{"key":"679_CR23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2567.2007.02672.x","volume":"122","author":"J Tanabe","year":"2007","unstructured":"Tanabe J, Izawa A, Takemi N, Miyauchi Y, Torii Y, Tsuchiyama H, et al. Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects. Immunology. 2007;122:562\u201370.","journal-title":"Immunology"},{"key":"679_CR24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.1840380415","volume":"38","author":"Y Inagaki","year":"2003","unstructured":"Inagaki Y, Nemoto T, Kushida M, Sheng Y, Higashi K, Ikeda K, et al. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology. 2003;38:890\u20139.","journal-title":"Hepatology"},{"key":"679_CR25","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/j.1572-0241.2006.00743.x","volume":"101","author":"D Rincon","year":"2006","unstructured":"Rincon D, Ripoll C, Lo Iacono O, Salcedo M, Catelina MV, Alvarez E, et al. Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis. Am J Gastroenterol. 2006;101:2269\u201374.","journal-title":"Am J Gastroenterol"},{"key":"679_CR26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.cgh.2007.02.022","volume":"5","author":"S Roberts","year":"2007","unstructured":"Roberts S, Gordon A, McLean C, Pedersen J, Bowden S, Thomson K, Augus P. Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis. Clin Gastroenterol Hepatol. 2007;5:932\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"679_CR27","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","volume":"359","author":"AM Bisceglie Di","year":"2008","unstructured":"Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everthart JE, Wright EC, et al. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008;359:2429\u201341.","journal-title":"N Engl J Med"},{"key":"679_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejrad.2009.06.011","volume":"76","author":"H Kodama","year":"2010","unstructured":"Kodama H, Aikata H, Takaki S, Azakami T, Katamura Y, Kawaoka T, et al. Evaluation of portosystemic collaterals by MDCT-MPR imaging for management of hemorrhagic esophageal varices. Eur J Radiol. 2010;76:239\u201345.","journal-title":"Eur J Radiol"},{"key":"679_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2214\/AJR.08.1268","volume":"192","author":"H Kodama","year":"2009","unstructured":"Kodama H, Aikata H, Takaki S, Takahashi S, Toyota N, Ito K, et al. Evaluation of patients with esophageal varices after endoscopic injection sclerotherapy using multiplanar reconstruction MDCT images. AJR Am J Roentgenol. 2009;192:122\u201330.","journal-title":"AJR Am J Roentgenol"},{"key":"679_CR30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jmv.20562","volume":"78","author":"M Kobayashi","year":"2006","unstructured":"Kobayashi M, Ikeda K, Hosaka T, Sezaki H, Someya T, Akuta N, et al. Natural history of compensated cirrhosis in the Child\u2013Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections. J Med Virol. 2006;78:459\u201365.","journal-title":"J Med Virol"},{"key":"679_CR31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hep.21492","volume":"45","author":"S Bruno","year":"2007","unstructured":"Bruno S, Stroffolini T, Colombo M, Bollani S, Benvegn\u00fa L, Mazzella G, et al. Sustained virological response to interferon-\u03b1 is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology. 2007;45:579\u201387.","journal-title":"Hepatology"},{"key":"679_CR32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.23744","volume":"52","author":"TR Morgan","year":"2010","unstructured":"Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, De Santo JL, Lee WM, et al. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology. 2010;52:833\u201344.","journal-title":"Hepatology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-012-0679-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-012-0679-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-012-0679-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:38:03Z","timestamp":1559097483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-012-0679-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1007\/s00535-012-0679-8","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,5]]}}}